Page last updated: 2024-08-16

sb 239063 and fidarestat

sb 239063 has been researched along with fidarestat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agthong, S; Middlemas, AB; Price, SA; Tomlinson, DR	1

Other Studies

1 other study(ies) available for sb 239063 and fidarestat

Article	Year
Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes, 2004, Volume: 53, Issue:7 Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Activation; Enzyme Inhibitors; Ganglia, Spinal; Imidazoles; Imidazolidines; Insulin; Male; Mitogen-Activated Protein Kinases; Motor Neurons; Neural Conduction; Neurons, Afferent; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Wistar; Spinal Cord; Time Factors; Tissue Distribution	2004

Article

Year

Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.

Diabetes, 2004, Volume: 53, Issue:7

Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Activation; Enzyme Inhibitors; Ganglia, Spinal; Imidazoles; Imidazolidines; Insulin; Male; Mitogen-Activated Protein Kinases; Motor Neurons; Neural Conduction; Neurons, Afferent; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Wistar; Spinal Cord; Time Factors; Tissue Distribution

2004